Keisuke Aoe

6.5k total citations
105 papers, 3.4k citations indexed

About

Keisuke Aoe is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Keisuke Aoe has authored 105 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Pulmonary and Respiratory Medicine, 49 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Keisuke Aoe's work include Occupational and environmental lung diseases (38 papers), Pleural and Pulmonary Diseases (31 papers) and Lung Cancer Treatments and Mutations (29 papers). Keisuke Aoe is often cited by papers focused on Occupational and environmental lung diseases (38 papers), Pleural and Pulmonary Diseases (31 papers) and Lung Cancer Treatments and Mutations (29 papers). Keisuke Aoe collaborates with scholars based in Japan, United States and Taiwan. Keisuke Aoe's co-authors include Katsuyuki Kiura, Akio Hiraki, Hiroshi Ueoka, Shinichi Toyooka, Takumi Kishimoto, Hiroaki Asano, Nobukazu Fujimoto, Junichi Soh, Hiroshi Date and Motoi Aoe and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Keisuke Aoe

103 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keisuke Aoe Japan 31 2.1k 1.5k 872 587 346 105 3.4k
Sun Min Lim South Korea 27 1.6k 0.8× 1.5k 1.0× 900 1.0× 521 0.9× 121 0.3× 132 2.8k
Mototsugu Shimokawa Japan 34 1.5k 0.7× 2.1k 1.3× 526 0.6× 411 0.7× 438 1.3× 306 3.8k
Marco Merlano Italy 35 1.4k 0.6× 2.2k 1.5× 1.3k 1.5× 708 1.2× 148 0.4× 188 4.6k
Katsunobu Sakurai Japan 30 971 0.5× 1.2k 0.8× 496 0.6× 445 0.8× 509 1.5× 141 2.8k
Paolo Bidoli Italy 27 1.9k 0.9× 2.0k 1.3× 531 0.6× 292 0.5× 103 0.3× 127 3.1k
Rajesh Malik United States 23 959 0.5× 629 0.4× 648 0.7× 193 0.3× 359 1.0× 88 2.3k
Yusuke Okuma Japan 24 936 0.4× 1.6k 1.0× 549 0.6× 273 0.5× 102 0.3× 186 2.5k
Wei Phin Tan United States 28 892 0.4× 1.2k 0.8× 926 1.1× 552 0.9× 72 0.2× 128 3.0k
Eva Lieto Italy 31 1.1k 0.5× 1.7k 1.1× 625 0.7× 443 0.8× 84 0.2× 67 3.1k
Sophie Ferlicot France 29 825 0.4× 454 0.3× 902 1.0× 369 0.6× 217 0.6× 124 2.5k

Countries citing papers authored by Keisuke Aoe

Since Specialization
Citations

This map shows the geographic impact of Keisuke Aoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Aoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Aoe more than expected).

Fields of papers citing papers by Keisuke Aoe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Aoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Aoe. The network helps show where Keisuke Aoe may publish in the future.

Co-authorship network of co-authors of Keisuke Aoe

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Aoe. A scholar is included among the top collaborators of Keisuke Aoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Aoe. Keisuke Aoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawai, Toshiaki, Kuniharu Miyajima, Hiroshi Nakashima, et al.. (2021). Malignant pleural mesothelioma with heterologous elements. Journal of Clinical Pathology. 75(10). 690–695. 2 indexed citations
2.
Nakagawa, Kazuhiko, Takashi Kijima, Morihito Okada, et al.. (2021). Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma. JTO Clinical and Research Reports. 2(6). 100178–100178. 5 indexed citations
3.
Oze, Isao, Keisuke Aoe, Katsuyuki Hotta, et al.. (2019). Physician requests by patients with malignant pleural mesothelioma in Japan. BMC Cancer. 19(1). 383–383. 10 indexed citations
4.
Uchibori, Ken, Miyako Satouchi, Naoko Sueoka‐Aragane, et al.. (2018). Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations. Lung Cancer. 124. 65–70. 13 indexed citations
5.
Fujimoto, Nobukazu, Keisuke Aoe, Toshiyuki Kozuki, et al.. (2018). A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol. Clinical Lung Cancer. 19(5). e705–e707. 20 indexed citations
6.
Oze, Isao, Keisuke Aoe, Katsuyuki Hotta, et al.. (2018). Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study. BMC Cancer. 18(1). 350–350. 12 indexed citations
7.
Satouchi, Miyako, Katsuyuki Hotta, Kaname Nosaki, et al.. (2017). Japan subset of Phase III study KEYNOTE-024: Pembrolizumab for PD-L1 TPS > =50%, treatment-naïve NSCLC. Annals of Oncology. 28. ix73–ix73. 2 indexed citations
8.
Hotta, Katsuyuki, Keisuke Aoe, Toshiyuki Kozuki, et al.. (2017). A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 13(2). 273–279. 123 indexed citations
9.
Ohashi, Kadoaki, Katsuyuki Hotta, Taizo Hirata, et al.. (2016). Trastuzumab Emtansine in HER2+ Recurrent Metastatic Non–Small-Cell Lung Cancer: Study Protocol. Clinical Lung Cancer. 18(1). 92–95. 16 indexed citations
10.
Aoe, Keisuke, Vishwa Jeet Amatya, Nobukazu Fujimoto, et al.. (2012). CD26 Overexpression Is Associated with Prolonged Survival and Enhanced Chemosensitivity in Malignant Pleural Mesothelioma. Clinical Cancer Research. 18(5). 1447–1456. 49 indexed citations
11.
Gemba, Kenichi, Nobukazu Fujimoto, Keisuke Aoe, et al.. (2012). Treatment and survival analyses of malignant mesothelioma in Japan. Acta Oncologica. 52(4). 803–808. 39 indexed citations
12.
Kishimoto, Takumi, Kenichi Gemba, Nobukazu Fujimoto, et al.. (2010). Clinical study on mesothelioma in Japan: Relevance to occupational asbestos exposure. American Journal of Industrial Medicine. 53(11). 1081–1087. 12 indexed citations
13.
Yamada, Noriyuki, Satoshi Oizumi, Eiki Kikuchi, et al.. (2010). CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection. Cancer Immunology Immunotherapy. 59(10). 1543–1549. 133 indexed citations
14.
Yamazaki, Hiroto, Satoshi Iwata, Toshihiro Okamoto, et al.. (2010). Identification of cancer stem cell markers in human malignant mesothelioma cells. Biochemical and Biophysical Research Communications. 404(2). 735–742. 67 indexed citations
15.
Toyooka, Shinichi, Toshimi Takano, Takayuki Kosaka, et al.. (2008). Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib‐treated patients with lung adenocarcinoma. Cancer Science. 99(2). 303–308. 30 indexed citations
16.
Aoe, Keisuke, Akio Hiraki, Tomoyuki Murakami, et al.. (2006). Infrequent existence of simian virus 40 large T antigen DNA in malignant mesothelioma in Japan. Cancer Science. 97(4). 292–295. 23 indexed citations
17.
Hiraki, Akio, Tomoyuki Murakami, Keisuke Aoe, et al.. (2006). Heterogeneous nuclear ribonucleoprotein B1 expression in malignant mesothelioma. Cancer Science. 97(11). 1175–1181. 5 indexed citations
18.
Soh, Junichi, Shinichi Toyooka, Keisuke Aoe, et al.. (2006). Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer. International Journal of Cancer. 119(10). 2353–2358. 94 indexed citations
19.
Aoe, Keisuke, Keiichi Fujiwara, Hideki Katayama, et al.. (2005). The symptoms of advanced lung cancer in terminal stage. 59(10). 539–542. 1 indexed citations
20.
Tada, Atsuhiko, Hiroshi Ueoka, Katsuyuki Kiura, et al.. (2002). [Combination chemotherapy with carboplatin and etoposide for elderly patients aged 76 years or older with small cell lung cancer].. PubMed. 29(5). 751–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sun Min Lim Breakdown of academic impact, for papers by Mototsugu Shimokawa Breakdown of academic impact, for papers by Marco Merlano Breakdown of academic impact, for papers by Katsunobu Sakurai Breakdown of academic impact, for papers by Paolo Bidoli Breakdown of academic impact, for papers by Rajesh Malik Breakdown of academic impact, for papers by Yusuke Okuma Breakdown of academic impact, for papers by Wei Phin Tan Breakdown of academic impact, for papers by Eva Lieto Breakdown of academic impact, for papers by Sophie Ferlicot
Rankless by CCL
2026